Frontlight ResearchEarly access
Trial site
EMED Centrum Usług Medycznych Ewa Śmiałek
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Asthma3 trials
- Atrial fibrillation1 trial
- Chronic spontaneous urticaria1 trial
- COPD1 trial
- Idiopathic pulmonary fibrosis1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Areteia Therapeutics1 trial
- Celldex Therapeutics Inc.1 trial
- Chiesi Farmaceutici S.p.A.1 trial
- GlaxoSmithKline1 trial
- Regeneron Pharmaceuticals1 trial
- and 3 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Chronic spontaneous urticaria1 recruiting
- COPD1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026